16 September 1986
7 April 1986
COMMERCIAL ITEM DESCRIPTION
PENTOXIFYLLINE TABLETS, (SUSTAINED-RELEASE)
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Pentoxifylline Tablets, Sustained-Release. Shall contain 400 mg of Pentoxifylline in a† controlled release formulation, per tablet, within the applicable assay limits.
Workmanship. The Tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle containing 100 tablet, as specified,† constitutes one unit.
Contractor certification. The contractor shall certify and maintain substantiating evidence that the product offered meets the salient characteristics of this Commercial Item Description, and that the product conforms to the producersí own drawings, specifications, standards, and quality assurance practices. The government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business